Health Freedom Protection Act

Summary

Health Freedom Protection Act - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to provide that a food or dietary supplement is not a drug solely because the label or labeling contains a claim to cure, mitigate, treat, or prevent disease. Prohibits the Secretary of Health and Human Services from: (1) restricting the reprinting and distribution or sale of any U.S. government publication or any accurate quotations of such a publication, including content concerning nutrients and disease treatment or prevention; or (2) construing the distribution or sale of, or accurate quotation from, such a publication in connection with the sale of a food or dietary supplement as evidence of an intent to sell that food or dietary supplement as a drug. Requires the Secretary to allow claims on food or nutrient labeling that characterize the relationship of a nutrient to the cure, mitigation, treatment, or prevention of a disease (with no more than a three-sentence disclaimer) unless the Secretary proves by clear and convincing evidence that: (1) there is no scientific evidence that supports the claim; and (2) the claim is inherently misleading and incapable of being rendered nonmisleading through the addition of a disclaimer. Authorizes the use of specified health claims on the label of all foods and dietary supplements, including claims related to saw palmetto, omega-3 fatty acids, glucosamine, and calcium. Allows a statement for a dietary supplement to include words that are recognized as signs or symptoms of disease so long as the statement does not include the name of a specific disease. Amends the Federal Trade Commission Act to exempt from being regulated as advertising: (1) government publications exempted from reprinting or distribution restrictions under FFDCA; or (2) accurate summaries of scientific publications. Places the burden of proof that an advertisement for a dietary supplement or ingredient is false and misleading on the Federal Trade Commission.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 2 May 2007

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

2. 2 May 2007

   Introduced

   Referred to the House Committee on Energy and Commerce.

   Source: IntroReferral

3. 2 May 2007

   Introduced

   Sponsor introductory remarks on measure. (CR E925)

   Source: IntroReferral

4. 2 May 2007

   Introduced

   Introduced in House

   Source: IntroReferral

5. 2 May 2007

   Introduced

   Introduced in House

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Introduced in House · 2 May 2007 · Official file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 2 May 2007

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 2 May 2007

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 2 May 2007

  Open at official source

Sponsors

• Rep. Paul, Ron [R-TX-22] · R · Sponsor
• Rep. Burton, Dan [R-IN-6] · R · Sponsor
• Rep. Shays, Christopher [R-CT-4] · R · Sponsor
• Rep. Bartlett, Roscoe G. [R-MD-6] · R · Sponsor
• JOHN DUNCAN · R · Sponsor
• Rescom. Fortuno, Luis G. [R-PR-At Large] · R · Cosponsor
• PETER DEFAZIO · D · Cosponsor
• Rep. Kuhl, John R. "Randy", Jr. [R-NY-29] · R · Cosponsor
• Rep. Musgrave, Marilyn N. [R-CO-4] · R · Cosponsor
• DANA ROHRABACHER · R · Cosponsor
• · hsif00 · Standing

Related records

No cross-record relationships stored yet.